{"id": "F6.1-000155-S1", "question": "Which genes predict resistance to Olaparib or Afimoxifene in Malignant Tumor Of The Breast?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Olaparib')\n  OR toLower(t.name) = toLower('Afimoxifene')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Olaparib'))\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Afimoxifene'))\n  OR toLower(t.name) CONTAINS toLower('Olaparib')\n  OR toLower(t.name) CONTAINS toLower('Afimoxifene')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(t.name) = toLower('Olaparib')\n    OR toLower(t.name) = toLower('Afimoxifene')\n    OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Olaparib'))\n    OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Afimoxifene'))\n    OR toLower(t.name) CONTAINS toLower('Olaparib')\n    OR toLower(t.name) CONTAINS toLower('Afimoxifene')\n)\nAND toLower(rel.effect) = 'resistance'\nAND toLower(rel.disease_name) CONTAINS toLower('malignant')\nAND toLower(rel.disease_name) CONTAINS toLower('tumor')\nAND toLower(rel.disease_name) CONTAINS toLower('breast')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n    CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n    t.name AS therapy_name,\n    rel.disease_name AS disease_name,\n    coalesce(rel.pmids, []) AS pmids_list\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids_list AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n    NULL AS variant_name,\n    gene_symbol,\n    therapy_name,\n    'resistance' AS effect,\n    disease_name,\n    pmids\nLIMIT 100", "gold_rows": [{"variant_name": null, "gene_symbol": "FGFR1", "therapy_name": "Afimoxifene", "effect": "resistance", "disease_name": "Breast Cancer", "pmids": ["20179196"]}, {"variant_name": null, "gene_symbol": "BRCA1", "therapy_name": "Olaparib", "effect": "resistance", "disease_name": "Triple-receptor Negative Breast Cancer", "pmids": ["21862407"]}, {"variant_name": null, "gene_symbol": "PARP1", "therapy_name": "Olaparib", "effect": "resistance", "disease_name": "Breast Cancer", "pmids": ["25144364"]}], "generated_rows": [], "error": null}
{"id": "F6.1-000161-S1-P1", "question": "In Malignant Tumor Of The Breast, which genes confer resistance to Pan-AKT Kinase Inhibitor GSK690693 or Aromatase Inhibitor?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Pan-AKT Kinase Inhibitor GSK690693')\n  OR toLower(t.name) = toLower('Aromatase Inhibitor')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Pan-AKT Kinase Inhibitor GSK690693'))\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Aromatase Inhibitor'))\n  OR toLower(t.name) CONTAINS toLower('Pan-AKT Kinase Inhibitor GSK690693')\n  OR toLower(t.name) CONTAINS toLower('Aromatase Inhibitor')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE toLower(rel.effect) = 'resistance'\n  AND toLower(rel.disease_name) CONTAINS 'malignant'\n  AND toLower(rel.disease_name) CONTAINS 'tumor'\n  AND toLower(rel.disease_name) CONTAINS 'breast'\n  AND (\n    toLower(t.name) = 'gsk690693'\n    OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = 'gsk690693')\n    OR toLower(t.name) CONTAINS 'gsk690693'\n    OR any(tag IN coalesce(t.tags, []) WHERE toLower(tag) CONTAINS 'pan-akt kinase inhibitor')\n    OR toLower(t.name) CONTAINS 'pan-akt kinase inhibitor'\n    OR any(tag IN coalesce(t.tags, []) WHERE toLower(tag) CONTAINS 'aromatase inhibitor')\n    OR toLower(t.name) CONTAINS 'aromatase inhibitor'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE\n    WHEN b:Gene THEN b.symbol\n    WHEN b:Variant THEN g.symbol\n    ELSE NULL\n  END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, effect, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  effect,\n  disease_name,\n  pmids\nLIMIT 100", "gold_rows": [{"variant_name": null, "gene_symbol": "ESR1", "therapy_name": "Aromatase Inhibitor", "effect": "resistance", "disease_name": "Estrogen-receptor Positive Breast Cancer", "pmids": ["24185512"]}, {"variant_name": null, "gene_symbol": "KMT2C", "therapy_name": "Aromatase Inhibitor", "effect": "resistance", "disease_name": "Breast Cancer", "pmids": ["29755131"]}, {"variant_name": null, "gene_symbol": "AKT3", "therapy_name": "Pan-AKT Kinase Inhibitor GSK690693", "effect": "resistance", "disease_name": "Breast Cancer", "pmids": ["24335962"]}], "generated_rows": [], "error": null}
{"id": "F6.2-000198-S1-P2", "question": "List therapies targeting TOP1 (not PTK6) with evidence in Carcinoma Of Colon.", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('PTK6')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('PTK6'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'colon' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g_target:Gene)\nWHERE toLower(g_target.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(g_target.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('PTK6')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('PTK6'))\nWITH t, g_target, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (b:Gene AND b.hgnc_id = g_target.hgnc_id)\n   OR (b:Variant AND EXISTS { (b)-[:VARIANT_OF]->(g_target) })\nAND toLower(rel.disease_name) CONTAINS toLower('colon')\nAND toLower(rel.disease_name) CONTAINS toLower('carcinoma')\nWITH\n  g_target.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  rel.effect AS effect,\n  coalesce(rel.pmids, []) AS pmids_list\nUNWIND pmids_list AS p\nWITH gene_symbol, therapy_name, disease_name, effect, collect(DISTINCT p) AS pmids_aggregated\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  effect,\n  disease_name,\n  pmids_aggregated AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "MSH3 K383fs", "gene_symbol": "MSH3", "therapy_name": "7-Ethyl-10-Hydroxycamptothecin", "effect": "sensitivity", "disease_name": "Colon Carcinoma", "pmids": ["23724141"]}], "generated_rows": [], "error": null}
{"id": "F6.2-000109-S1-P2", "question": "List therapies targeting TOP1 (not PSMB6) with evidence in Carcinoma Of Colon.", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('PSMB6')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('PSMB6'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'colon' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('PSMB6')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('PSMB6'))\nWITH t, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.disease_name) CONTAINS toLower('carcinoma')\n  AND toLower(rel.disease_name) CONTAINS toLower('colon')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, effect, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  effect,\n  disease_name,\n  pmids\nLIMIT 100", "gold_rows": [{"variant_name": "MSH3 K383fs", "gene_symbol": "MSH3", "therapy_name": "7-Ethyl-10-Hydroxycamptothecin", "effect": "sensitivity", "disease_name": "Colon Carcinoma", "pmids": ["23724141"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "MSH3", "therapy_name": "7-Ethyl-10-Hydroxycamptothecin", "effect": "sensitivity", "disease_name": "Colon Carcinoma", "pmids": ["23724141"]}], "error": null}
{"id": "F6.2-000182-S1-P1", "question": "Which drugs hit TOP1 but not TACSTD2 with evidence in Colonic Carcinoma?", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('TACSTD2')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('TACSTD2'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'colon' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g1:Gene)\nWHERE toLower(g1.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(g1.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\n\nOPTIONAL MATCH (t)-[:TARGETS]->(g2:Gene)\nWHERE toLower(g2.symbol) = toLower('TACSTD2')\n   OR any(s IN coalesce(g2.synonyms, []) WHERE toLower(s) = toLower('TACSTD2'))\n\nWITH t, g1, g2\nWHERE g2 IS NULL\n\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.disease_name) CONTAINS toLower('colonic')\n  AND toLower(rel.disease_name) CONTAINS toLower('carcinoma')\n\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\n\nRETURN\n  NULL AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "MSH3 K383fs", "gene_symbol": "MSH3", "therapy_name": "7-Ethyl-10-Hydroxycamptothecin", "effect": "sensitivity", "disease_name": "Colon Carcinoma", "pmids": ["23724141"]}], "generated_rows": [], "error": null}
{"id": "F5.2-000055-S2-P2", "question": "Show drugs with variant-based evidence in Primary Myelofibrosis.", "gold_cypher": "MATCH (v:Variant)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'myelofibrosis'\n  )\nOPTIONAL MATCH (v)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Variant:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE toLower(rel.disease_name) CONTAINS toLower('primary')\n  AND toLower(rel.disease_name) CONTAINS toLower('myelofibrosis')\nMATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  coalesce(b.name, b.hgvs_p) AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "NTRK2 A203T", "gene_symbol": "NTRK2", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Myelofibrosis", "pmids": ["32315394"]}, {"variant_name": "NTRK2 A203T", "gene_symbol": "NTRK2", "therapy_name": "Larotrectinib", "effect": "sensitivity", "disease_name": "Myelofibrosis", "pmids": ["32315394"]}], "generated_rows": [], "error": null}
{"id": "F5.2-000073-S1-P3", "question": "List treatments supported by variant evidence in Osteogenic Sarcoma.", "gold_cypher": "MATCH (v:Variant)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'osteosarcoma'\n  )\nOPTIONAL MATCH (v)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Variant)-[:VARIANT_OF]->(g:Gene),\n      (b)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE toLower(rel.disease_name) CONTAINS toLower('osteogenic')\n  AND toLower(rel.disease_name) CONTAINS toLower('sarcoma')\nRETURN\n  coalesce(b.name, b.hgvs_p) AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "ATRX Underexpression", "gene_symbol": "ATRX", "therapy_name": "AZ20", "effect": "sensitivity", "disease_name": "Osteosarcoma", "pmids": ["25593184"]}, {"variant_name": "ERCC2 K751Q", "gene_symbol": "ERCC2", "therapy_name": "Cisplatin", "effect": "resistance", "disease_name": "Osteosarcoma", "pmids": ["19434073"]}, {"variant_name": "TP53 R273H", "gene_symbol": "TP53", "therapy_name": "Doxorubicin", "effect": "resistance", "disease_name": "Osteosarcoma", "pmids": ["17363498"]}, {"variant_name": "TP53 R273H", "gene_symbol": "TP53", "therapy_name": "Methotrexate", "effect": "resistance", "disease_name": "Osteosarcoma", "pmids": ["17363498"]}, {"variant_name": "RB1 Loss-of-function", "gene_symbol": "RB1", "therapy_name": "Niraparib", "effect": "sensitivity", "disease_name": "Osteosarcoma", "pmids": ["34862364"]}, {"variant_name": "RB1 Loss-of-function", "gene_symbol": "RB1", "therapy_name": "Olaparib", "effect": "sensitivity", "disease_name": "Osteosarcoma", "pmids": ["34862364"]}, {"variant_name": "RB1 Loss-of-function", "gene_symbol": "RB1", "therapy_name": "Talazoparib", "effect": "sensitivity", "disease_name": "Osteosarcoma", "pmids": ["34862364"]}, {"variant_name": "ZNF217 Overexpression", "gene_symbol": "ZNF217", "therapy_name": "Triciribine", "effect": "sensitivity", "disease_name": "Osteosarcoma", "pmids": ["32999043"]}, {"variant_name": "ATRX Underexpression", "gene_symbol": "ATRX", "therapy_name": "VE-821", "effect": "sensitivity", "disease_name": "Osteosarcoma", "pmids": ["25593184"]}], "generated_rows": [], "error": null}
{"id": "F2.2-000073-S1", "question": "How does the variant SQSTM1 SQSTM1::NTRK1 Fusion affect response to Larotrectinib in Bronchogenic Lung Adenocarcinoma?", "gold_cypher": "MATCH (v:Variant {name: 'SQSTM1 SQSTM1::NTRK1 Fusion'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Larotrectinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Larotrectinib'))\n  OR toLower(t.name) CONTAINS toLower('Larotrectinib')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'adenocarcinoma'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker:Variant)-[:VARIANT_OF]->(g:Gene)\nMATCH (b)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(b.name) = toLower('SQSTM1 SQSTM1::NTRK1 Fusion')\n    OR toLower(b.name) CONTAINS toLower('SQSTM1::NTRK1')\n    OR toLower(b.name) CONTAINS toLower('NTRK1::SQSTM1')\n)\nAND (\n    toLower(g.symbol) = toLower('SQSTM1') OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('SQSTM1'))\n    OR toLower(g.symbol) = toLower('NTRK1') OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('NTRK1'))\n)\nAND (\n    toLower(t.name) = toLower('Larotrectinib')\n    OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Larotrectinib'))\n    OR toLower(t.name) CONTAINS toLower('Larotrectinib')\n)\nAND toLower(rel.disease_name) CONTAINS toLower('bronchogenic')\nAND toLower(rel.disease_name) CONTAINS toLower('lung')\nAND toLower(rel.disease_name) CONTAINS toLower('adenocarcinoma')\nRETURN\n    coalesce(b.name, b.hgvs_p) AS variant_name,\n    g.symbol AS gene_symbol,\n    t.name AS therapy_name,\n    rel.effect AS effect,\n    rel.disease_name AS disease_name,\n    coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "SQSTM1 SQSTM1::NTRK1 Fusion", "gene_symbol": "SQSTM1", "therapy_name": "Larotrectinib", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["35085007"]}], "generated_rows": [], "error": null}
{"id": "F2.2-000077-S2", "question": "How does the variant KRAS G12C affect response to Trametinib in Non-small Cell Lung Cancer?", "gold_cypher": "MATCH (v:Variant {name: 'KRAS G12C'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Trametinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Trametinib'))\n  OR toLower(t.name) CONTAINS toLower('Trametinib')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker:Variant)-[:VARIANT_OF]->(g:Gene)\nWHERE (toLower(g.symbol) = toLower('KRAS')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('KRAS')))\nAND toLower(b.name) = toLower('KRAS G12C')\nMATCH (b)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (toLower(t.name) = toLower('Trametinib')\n   OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Trametinib'))\n   OR toLower(t.name) CONTAINS toLower('Trametinib'))\nAND toLower(rel.disease_name) CONTAINS toLower('lung')\nAND toLower(rel.disease_name) CONTAINS toLower('non-small')\nAND toLower(rel.disease_name) CONTAINS toLower('cell')\nAND toLower(rel.disease_name) CONTAINS toLower('cancer')\nRETURN\n  b.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "KRAS G12C", "gene_symbol": "KRAS", "therapy_name": "Trametinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31666701"]}], "generated_rows": [], "error": null}
{"id": "F2.2-000085-P3", "question": "How does MET Amplification AND MET Splice Site (c.3028G>A) influence response to Crizotinib for Lung Non-small Cell Carcinoma?", "gold_cypher": "MATCH (v:Variant {name: 'MET Amplification AND MET Splice Site (c.3028G>A)'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Crizotinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Crizotinib'))\n  OR toLower(t.name) CONTAINS toLower('Crizotinib')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(t.name) = toLower('crizotinib')\n    OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('crizotinib'))\n    OR toLower(t.name) CONTAINS toLower('crizotinib')\n)\nAND toLower(rel.disease_name) CONTAINS toLower('lung')\nAND toLower(rel.disease_name) CONTAINS toLower('non-small')\nAND toLower(rel.disease_name) CONTAINS toLower('cell')\nAND toLower(rel.disease_name) CONTAINS toLower('carcinoma')\nAND b:Variant\nMATCH (b)-[:VARIANT_OF]->(g:Gene)\nWHERE (\n    toLower(g.symbol) = toLower('MET')\n    OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('MET'))\n)\nAND (\n    toLower(b.name) CONTAINS toLower('amplification')\n    OR toLower(b.name) = toLower('MET Splice Site (c.3028G>A)')\n    OR toLower(b.hgvs_p) = toLower('c.3028G>A')\n)\nRETURN\n    coalesce(b.name, b.hgvs_p) AS variant_name,\n    g.symbol AS gene_symbol,\n    t.name AS therapy_name,\n    rel.effect AS effect,\n    rel.disease_name AS disease_name,\n    coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "MET Amplification AND MET Splice Site (c.3028G>A)", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26729443"]}], "generated_rows": [{"variant_name": "MET Amplification", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31584608", "21623265", "27664533", "21716144"]}, {"variant_name": "MET Amplification AND MET Splice Site (c.3028G>A)", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26729443"]}], "error": null}
{"id": "F4.1-000114-S2-P3", "question": "Show treatments hitting AKT1 that have biomarker evidence in Conventional (Clear Cell) Renal Cell Carcinoma.", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('AKT1')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('AKT1'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'clear' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'renal' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(bg:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE bg.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('AKT1')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('AKT1'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.disease_name) CONTAINS toLower('conventional')\n  AND toLower(rel.disease_name) CONTAINS toLower('clear')\n  AND toLower(rel.disease_name) CONTAINS toLower('cell')\n  AND toLower(rel.disease_name) CONTAINS toLower('renal')\n  AND toLower(rel.disease_name) CONTAINS toLower('carcinoma')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(gene_of_variant:Gene)\nRETURN\n  CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE gene_of_variant.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "SETD2 Loss", "gene_symbol": "SETD2", "therapy_name": "Akt Inhibitor MK2206", "effect": "sensitivity", "disease_name": "Clear Cell Renal Cell Carcinoma", "pmids": ["31695846"]}], "generated_rows": [], "error": null}
{"id": "F4.1-000034-S2-P1", "question": "What drugs targeting ALK have biomarker evidence in Naevocarcinoma?", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'melanoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(bg:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE bg.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g_target:Gene)\nWHERE toLower(g_target.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g_target.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.disease_name) CONTAINS toLower('naevocarcinoma')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n    CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n    t.name AS therapy_name,\n    rel.effect AS effect,\n    rel.disease_name AS disease_name,\n    coalesce(rel.pmids, []) AS pmids_list\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids_list AS pmid\nWITH gene_symbol, therapy_name, effect, disease_name, collect(DISTINCT pmid) AS pmids\nRETURN\n    NULL AS variant_name,\n    gene_symbol,\n    therapy_name,\n    effect,\n    disease_name,\n    pmids\nLIMIT 100", "gold_rows": [{"variant_name": "ALK Alternative Transcript (ATI)", "gene_symbol": "ALK", "therapy_name": "ALK Inhibitor ASP3026", "effect": "sensitivity", "disease_name": "Melanoma", "pmids": ["29054983"]}, {"variant_name": "ALK Alternative Transcript (ATI)", "gene_symbol": "ALK", "therapy_name": "Alectinib", "effect": "sensitivity", "disease_name": "Melanoma", "pmids": ["29054983"]}, {"variant_name": "ALK Alternative Transcript (ATI)", "gene_symbol": "ALK", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Melanoma", "pmids": ["29054983"]}, {"variant_name": "ALK Alternative Transcript (ATI)", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Skin Melanoma", "pmids": ["26444240"]}, {"variant_name": "ALK Alternative Transcript (ATI)", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Melanoma", "pmids": ["29054983"]}, {"variant_name": "MET Overexpression", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Uveal Melanoma", "pmids": ["24140933"]}, {"variant_name": "ALK Alternative Transcript (ATI)", "gene_symbol": "ALK", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Mucosal Melanoma", "pmids": ["29054983"]}, {"variant_name": "ALK Alternative Transcript (ATI)", "gene_symbol": "ALK", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Melanoma", "pmids": ["29054983"]}, {"variant_name": "ETV6 ETV6::NTRK3 Fusion", "gene_symbol": "ETV6", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Melanoma", "pmids": ["35395680"]}, {"variant_name": "GOPC GOPC::ROS1 Fusion", "gene_symbol": "GOPC", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Melanoma", "pmids": ["28183697"]}], "generated_rows": [], "error": null}
{"id": "F4.1-000048-S1-P1", "question": "What drugs targeting ALK have biomarker evidence in Tumor Of Soft Tissue And Skeleton?", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'sarcoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(bg:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE bg.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.disease_name) CONTAINS toLower('tumor')\n  AND toLower(rel.disease_name) CONTAINS toLower('soft')\n  AND toLower(rel.disease_name) CONTAINS toLower('tissue')\n  AND toLower(rel.disease_name) CONTAINS toLower('skeleton')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g_variant:Gene)\nRETURN\n  CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g_variant.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "FUS FUS::TFCP2 Fusion AND ALK Exon 2-18 Deletion", "gene_symbol": "FUS", "therapy_name": "Alectinib", "effect": "sensitivity", "disease_name": "Spindle Cell Rhabdomyosarcoma", "pmids": ["39302072"]}, {"variant_name": "ERC1 ERC1::ALK Fusion", "gene_symbol": "ERC1", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Sarcoma", "pmids": ["34464935"]}, {"variant_name": "EWSR1 EWSR1::ATF1 Fusion", "gene_symbol": "EWSR1", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Clear Cell Sarcoma", "pmids": ["29741569"]}, {"variant_name": "LMNA LMNA::NTRK1 Fusion", "gene_symbol": "LMNA", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Congenital Fibrosarcoma", "pmids": ["30709876"]}, {"variant_name": "MET Amplification AND MET Exon 14 Skipping Mutation", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Sarcomatoid Carcinoma", "pmids": ["26215952"]}, {"variant_name": "MET Exon 14 Skipping Mutation AND MET Overexpression", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Sarcomatoid Carcinoma", "pmids": ["26709483"]}, {"variant_name": "MET Overexpression AND ALK Overexpression", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Alveolar Rhabdomyosarcoma", "pmids": ["26445453"]}, {"variant_name": "MET Overexpression AND EWSR1::ATF1 Fusion", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Clear Cell Sarcoma", "pmids": ["28950372"]}, {"variant_name": "MET Splice Site (c.3028+3A>G)", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Sarcomatoid Carcinoma", "pmids": ["36147925"]}, {"variant_name": "EML4 EML4::NTRK3 Fusion", "gene_symbol": "EML4", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Congenital Fibrosarcoma", "pmids": ["35395680"]}, {"variant_name": "ETV6 ETV6::NTRK3 Fusion", "gene_symbol": "ETV6", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Congenital Fibrosarcoma", "pmids": ["35395680"]}], "generated_rows": [], "error": null}
{"id": "F4.1-000114-S1-P3", "question": "Show treatments hitting AKT1 that have biomarker evidence in Clear Cell Kidney Carcinoma.", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('AKT1')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('AKT1'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'clear' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'renal' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(bg:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE bg.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g_target:Gene)\nWHERE toLower(g_target.symbol) = toLower('AKT1')\n   OR any(s IN coalesce(g_target.synonyms, []) WHERE toLower(s) = toLower('AKT1'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.disease_name) CONTAINS toLower('clear')\n  AND toLower(rel.disease_name) CONTAINS toLower('cell')\n  AND toLower(rel.disease_name) CONTAINS toLower('kidney')\n  AND toLower(rel.disease_name) CONTAINS toLower('carcinoma')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g_biomarker:Gene)\nRETURN\n  CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g_biomarker.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "SETD2 Loss", "gene_symbol": "SETD2", "therapy_name": "Akt Inhibitor MK2206", "effect": "sensitivity", "disease_name": "Clear Cell Renal Cell Carcinoma", "pmids": ["31695846"]}], "generated_rows": [], "error": null}
{"id": "F2.2-000007-S1", "question": "Which genes affect response to Infigratinib in Connective And Soft Tissue Neoplasm?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Infigratinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Infigratinib'))\n  OR toLower(t.name) CONTAINS toLower('Infigratinib')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'sarcoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  NULL AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(t.name) = toLower('infigratinib')\n    OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('infigratinib'))\n)\nAND toLower(rel.disease_name) CONTAINS toLower('connective')\nAND toLower(rel.disease_name) CONTAINS toLower('soft')\nAND toLower(rel.disease_name) CONTAINS toLower('tissue')\nAND toLower(rel.disease_name) CONTAINS toLower('neoplasm')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n    CASE\n        WHEN b:Gene THEN b.symbol\n        WHEN b:Variant AND g IS NOT NULL THEN g.symbol\n        ELSE NULL\n    END AS gene_symbol,\n    t.name AS therapy_name,\n    rel.effect AS effect,\n    rel.disease_name AS disease_name,\n    coalesce(rel.pmids, []) AS pmids_list\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids_list AS pmid_single\nWITH gene_symbol, therapy_name, effect, disease_name, collect(DISTINCT pmid_single) AS pmids\nRETURN\n    NULL AS variant_name,\n    gene_symbol,\n    therapy_name,\n    effect,\n    disease_name,\n    pmids\nLIMIT 100", "gold_rows": [{"variant_name": null, "gene_symbol": "FGFR1", "therapy_name": "Infigratinib", "effect": null, "disease_name": "Sarcoma", "pmids": ["27535980"]}], "generated_rows": [], "error": null}
{"id": "F2.2-000095", "question": "Which genes affect response to Onartuzumab in Gastric Adenocarcinoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Onartuzumab')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Onartuzumab'))\n  OR toLower(t.name) CONTAINS toLower('Onartuzumab')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'gastric' AND\n    toLower(rel.disease_name) CONTAINS 'adenocarcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  NULL AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(t.name) = toLower('onartuzumab')\n    OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('onartuzumab'))\n    OR toLower(t.name) CONTAINS toLower('onartuzumab')\n)\nAND toLower(rel.disease_name) CONTAINS toLower('gastric')\nAND toLower(rel.disease_name) CONTAINS toLower('adenocarcinoma')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n    CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n    t.name AS therapy_name,\n    rel.effect AS effect,\n    rel.disease_name AS disease_name,\n    coalesce(rel.pmids, []) AS pmids_list\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids_list AS p\nWITH gene_symbol, therapy_name, effect, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n    NULL AS variant_name,\n    gene_symbol,\n    therapy_name,\n    effect,\n    disease_name,\n    pmids\nLIMIT 100", "gold_rows": [{"variant_name": null, "gene_symbol": "MET", "therapy_name": "Onartuzumab", "effect": null, "disease_name": "Gastric Adenocarcinoma", "pmids": ["22389872"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "MET", "therapy_name": "Onartuzumab", "effect": "sensitivity", "disease_name": "Gastric Adenocarcinoma", "pmids": ["22389872"]}], "error": null}
{"id": "F2.2-000126-S1-P2", "question": "Which genes influence response to Fexagratinib for Non-small Cell Lung Cancer?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Fexagratinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Fexagratinib'))\n  OR toLower(t.name) CONTAINS toLower('Fexagratinib')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  NULL AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(t.name) = toLower('Fexagratinib')\n    OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Fexagratinib'))\n    OR toLower(t.name) CONTAINS toLower('Fexagratinib')\n)\nAND toLower(rel.disease_name) CONTAINS toLower('non-small')\nAND toLower(rel.disease_name) CONTAINS toLower('cell')\nAND toLower(rel.disease_name) CONTAINS toLower('lung')\nAND toLower(rel.disease_name) CONTAINS toLower('cancer')\nAND toLower(rel.effect) IN ['sensitivity', 'resistance']\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n    CASE\n        WHEN b:Gene THEN b.symbol\n        WHEN b:Variant AND g IS NOT NULL THEN g.symbol\n        ELSE NULL\n    END AS gene_symbol,\n    t.name AS therapy_name,\n    rel.effect AS effect,\n    rel.disease_name AS disease_name,\n    coalesce(rel.pmids, []) AS pmids_for_this_rel\nWHERE gene_symbol IS NOT NULL\nWITH gene_symbol, therapy_name, effect, disease_name, collect(pmids_for_this_rel) AS all_pmids_lists\nUNWIND all_pmids_lists AS pmid_sublist\nUNWIND pmid_sublist AS pmid\nWITH gene_symbol, therapy_name, effect, disease_name, collect(DISTINCT pmid) AS pmids\nRETURN\n    NULL AS variant_name,\n    gene_symbol,\n    therapy_name,\n    effect,\n    disease_name,\n    pmids\nLIMIT 100", "gold_rows": [{"variant_name": null, "gene_symbol": "FGFR1", "therapy_name": "Fexagratinib", "effect": null, "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23082000"]}], "generated_rows": [], "error": null}
{"id": "F2.2-000075-S1-P3", "question": "List genes with evidence affecting Dinaciclib in Serous Cystadenoma.", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Dinaciclib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Dinaciclib'))\n  OR toLower(t.name) CONTAINS toLower('Dinaciclib')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'ovarian' AND\n    toLower(rel.disease_name) CONTAINS 'serous' AND\n    toLower(rel.disease_name) CONTAINS 'cystadenocarcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  NULL AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(t.name) = toLower('Dinaciclib')\n    OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Dinaciclib'))\n    OR toLower(t.name) CONTAINS toLower('Dinaciclib')\n)\nAND toLower(rel.disease_name) CONTAINS toLower('serous')\nAND toLower(rel.disease_name) CONTAINS toLower('cystadenoma')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n    CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n    t.name AS therapy_name,\n    rel.effect AS effect,\n    rel.disease_name AS disease_name,\n    coalesce(rel.pmids, []) AS pmids_raw\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids_raw AS p\nWITH gene_symbol, therapy_name, effect, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n    NULL AS variant_name,\n    gene_symbol,\n    therapy_name,\n    effect,\n    disease_name,\n    pmids\nLIMIT 100", "gold_rows": [{"variant_name": null, "gene_symbol": "CCNE1", "therapy_name": "Dinaciclib", "effect": null, "disease_name": "Ovarian Serous Cystadenocarcinoma", "pmids": ["27663592"]}], "generated_rows": [], "error": null}
{"id": "F6.4-000176-S1-P3", "question": "Find alternative therapies targeting resistance genes for U0126 in Malignant Melanoma Of Skin Of Lower Limb.", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('U0126')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('U0126'))\n  OR toLower(t1.name) CONTAINS toLower('U0126')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'skin' AND\n    toLower(rel.disease_name) CONTAINS 'melanoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('U0126')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (t_initial:Therapy)\nWHERE toLower(t_initial.name) = toLower('U0126')\n   OR any(s IN coalesce(t_initial.synonyms, []) WHERE toLower(s) = toLower('U0126'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t_initial)\nWHERE toLower(rel.effect) = 'resistance'\n  AND toLower(rel.disease_name) CONTAINS toLower('malignant')\n  AND toLower(rel.disease_name) CONTAINS toLower('melanoma')\n  AND toLower(rel.disease_name) CONTAINS toLower('skin')\n  AND toLower(rel.disease_name) CONTAINS toLower('lower')\n  AND toLower(rel.disease_name) CONTAINS toLower('limb')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n    t_initial,\n    CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS resistance_gene_symbol,\n    rel.effect AS effect,\n    rel.disease_name AS disease_name,\n    coalesce(rel.pmids, []) AS pmids_list\nWHERE resistance_gene_symbol IS NOT NULL\nUNWIND pmids_list AS pmid\nWITH\n    t_initial,\n    resistance_gene_symbol,\n    effect,\n    disease_name,\n    collect(DISTINCT pmid) AS aggregated_pmids\nMATCH (t_alternative:Therapy)-[r:TARGETS]->(g_resistance:Gene)\nWHERE (toLower(g_resistance.symbol) = toLower(resistance_gene_symbol)\n   OR any(s IN coalesce(g_resistance.synonyms, []) WHERE toLower(s) = toLower(resistance_gene_symbol)))\n  AND t_alternative <> t_initial\nRETURN\n    NULL AS variant_name,\n    g_resistance.symbol AS gene_symbol,\n    t_alternative.name AS therapy_name,\n    effect,\n    disease_name,\n    aggregated_pmids AS pmids\nLIMIT 100", "gold_rows": [{"gene_symbol": "BRAF", "therapy_name": "Agerafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["http://ignyta.com/wp-content/uploads/2015/11/ENA-2015-poster-RXDX-105.pdf", "http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf"], "ref_urls": ["http://ignyta.com/wp-content/uploads/2015/11/ENA-2015-poster-RXDX-105.pdf", "http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "BRAF Inhibitor", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DOI", "PubMed"], "ref_ids": ["10.1158/1538-7445.AM2012-3790", "23617957"], "ref_urls": ["http://cancerres.aacrjournals.org/content/72/8_Supplement/3790", "http://europepmc.org/abstract/MED/23617957"]}, {"gene_symbol": "BRAF", "therapy_name": "Belvarafenib", "targets_moa": "RAF serine/threonine protein kinase inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["https://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.2570", "https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.3000"], "ref_urls": ["https://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.2570", "https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.3000"]}, {"gene_symbol": "BRAF", "therapy_name": "Dabrafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=803beaaa-33f9-48cc-9a95-c2e887e095b4#nlm34090-1"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=803beaaa-33f9-48cc-9a95-c2e887e095b4#nlm34090-1"]}, {"gene_symbol": "BRAF", "therapy_name": "Encorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DOI", "PubMed"], "ref_ids": ["10.1158/1538-7445.AM2012-3790", "23617957"], "ref_urls": ["http://cancerres.aacrjournals.org/content/72/8_Supplement/3790", "http://europepmc.org/abstract/MED/23617957"]}, {"gene_symbol": "BRAF", "therapy_name": "Pan-RAF Inhibitor LY3009120", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["25965804"], "ref_urls": ["http://europepmc.org/abstract/MED/25965804"]}, {"gene_symbol": "BRAF", "therapy_name": "Regorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Sorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "TRK Inhibitor", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Tovorafenib", "targets_moa": "RAF serine/threonine protein kinase inhibitor", "ref_sources": ["Other", "Other", "PubMed"], "ref_ids": ["http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=710688", "http://www.sunesis.com/products-in-development/product/MLN2480.php", "5653214"], "ref_urls": ["http://europepmc.org/abstract/MED/5653214", "http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=710688", "http://www.sunesis.com/products-in-development/product/MLN2480.php"]}, {"gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/202429s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202429s000lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Agerafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["http://ignyta.com/wp-content/uploads/2015/11/ENA-2015-poster-RXDX-105.pdf", "http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf"], "ref_urls": ["http://ignyta.com/wp-content/uploads/2015/11/ENA-2015-poster-RXDX-105.pdf", "http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "BRAF Inhibitor", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DOI", "PubMed"], "ref_ids": ["10.1158/1538-7445.AM2012-3790", "23617957"], "ref_urls": ["http://cancerres.aacrjournals.org/content/72/8_Supplement/3790", "http://europepmc.org/abstract/MED/23617957"]}, {"gene_symbol": "BRAF", "therapy_name": "Belvarafenib", "targets_moa": "RAF serine/threonine protein kinase inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["https://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.2570", "https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.3000"], "ref_urls": ["https://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.2570", "https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.3000"]}, {"gene_symbol": "BRAF", "therapy_name": "Dabrafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=803beaaa-33f9-48cc-9a95-c2e887e095b4#nlm34090-1"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=803beaaa-33f9-48cc-9a95-c2e887e095b4#nlm34090-1"]}, {"gene_symbol": "BRAF", "therapy_name": "Encorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DOI", "PubMed"], "ref_ids": ["10.1158/1538-7445.AM2012-3790", "23617957"], "ref_urls": ["http://cancerres.aacrjournals.org/content/72/8_Supplement/3790", "http://europepmc.org/abstract/MED/23617957"]}, {"gene_symbol": "BRAF", "therapy_name": "Pan-RAF Inhibitor LY3009120", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["25965804"], "ref_urls": ["http://europepmc.org/abstract/MED/25965804"]}, {"gene_symbol": "BRAF", "therapy_name": "Regorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Sorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "TRK Inhibitor", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Tovorafenib", "targets_moa": "RAF serine/threonine protein kinase inhibitor", "ref_sources": ["Other", "Other", "PubMed"], "ref_ids": ["http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=710688", "http://www.sunesis.com/products-in-development/product/MLN2480.php", "5653214"], "ref_urls": ["http://europepmc.org/abstract/MED/5653214", "http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=710688", "http://www.sunesis.com/products-in-development/product/MLN2480.php"]}, {"gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/202429s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202429s000lbl.pdf"]}], "generated_rows": [], "error": null}
{"id": "F6.4-000199-S2-P2", "question": "Which treatments target resistance biomarkers for Trametinib in Naevocarcinoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Trametinib')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Trametinib'))\n  OR toLower(t1.name) CONTAINS toLower('Trametinib')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'melanoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Trametinib')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t_trametinib:Therapy)\nWHERE (\n    toLower(t_trametinib.name) = toLower('trametinib')\n    OR any(s IN coalesce(t_trametinib.synonyms, []) WHERE toLower(s) = toLower('trametinib'))\n    OR toLower(t_trametinib.name) CONTAINS toLower('trametinib')\n)\nAND toLower(rel.effect) = 'resistance'\nAND toLower(rel.disease_name) CONTAINS toLower('naevocarcinoma')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nMATCH (t_targeting:Therapy)-[r_targets:TARGETS]->(g:Gene)\nRETURN\n    t_targeting.name AS therapy_name,\n    CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) END AS variant_name,\n    CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n    rel.effect AS effect,\n    rel.disease_name AS disease_name,\n    coalesce(rel.pmids, []) AS pmids,\n    r_targets.moa AS targets_moa,\n    coalesce(r_targets.ref_sources, []) AS ref_sources,\n    coalesce(r_targets.ref_ids, []) AS ref_ids,\n    coalesce(r_targets.ref_urls, []) AS ref_urls\nLIMIT 100", "gold_rows": [{"gene_symbol": "BRAF", "therapy_name": "Agerafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["http://ignyta.com/wp-content/uploads/2015/11/ENA-2015-poster-RXDX-105.pdf", "http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf"], "ref_urls": ["http://ignyta.com/wp-content/uploads/2015/11/ENA-2015-poster-RXDX-105.pdf", "http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "BRAF Inhibitor", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DOI", "PubMed"], "ref_ids": ["10.1158/1538-7445.AM2012-3790", "23617957"], "ref_urls": ["http://cancerres.aacrjournals.org/content/72/8_Supplement/3790", "http://europepmc.org/abstract/MED/23617957"]}, {"gene_symbol": "BRAF", "therapy_name": "Belvarafenib", "targets_moa": "RAF serine/threonine protein kinase inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["https://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.2570", "https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.3000"], "ref_urls": ["https://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.2570", "https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.3000"]}, {"gene_symbol": "BRAF", "therapy_name": "Dabrafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=803beaaa-33f9-48cc-9a95-c2e887e095b4#nlm34090-1"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=803beaaa-33f9-48cc-9a95-c2e887e095b4#nlm34090-1"]}, {"gene_symbol": "BRAF", "therapy_name": "Encorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DOI", "PubMed"], "ref_ids": ["10.1158/1538-7445.AM2012-3790", "23617957"], "ref_urls": ["http://cancerres.aacrjournals.org/content/72/8_Supplement/3790", "http://europepmc.org/abstract/MED/23617957"]}, {"gene_symbol": "BRAF", "therapy_name": "Pan-RAF Inhibitor LY3009120", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["25965804"], "ref_urls": ["http://europepmc.org/abstract/MED/25965804"]}, {"gene_symbol": "BRAF", "therapy_name": "Regorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Sorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "TRK Inhibitor", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Tovorafenib", "targets_moa": "RAF serine/threonine protein kinase inhibitor", "ref_sources": ["Other", "Other", "PubMed"], "ref_ids": ["http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=710688", "http://www.sunesis.com/products-in-development/product/MLN2480.php", "5653214"], "ref_urls": ["http://europepmc.org/abstract/MED/5653214", "http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=710688", "http://www.sunesis.com/products-in-development/product/MLN2480.php"]}, {"gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/202429s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202429s000lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Agerafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["http://ignyta.com/wp-content/uploads/2015/11/ENA-2015-poster-RXDX-105.pdf", "http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf"], "ref_urls": ["http://ignyta.com/wp-content/uploads/2015/11/ENA-2015-poster-RXDX-105.pdf", "http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "BRAF Inhibitor", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DOI", "PubMed"], "ref_ids": ["10.1158/1538-7445.AM2012-3790", "23617957"], "ref_urls": ["http://cancerres.aacrjournals.org/content/72/8_Supplement/3790", "http://europepmc.org/abstract/MED/23617957"]}, {"gene_symbol": "BRAF", "therapy_name": "Belvarafenib", "targets_moa": "RAF serine/threonine protein kinase inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["https://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.2570", "https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.3000"], "ref_urls": ["https://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.2570", "https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.3000"]}, {"gene_symbol": "BRAF", "therapy_name": "Dabrafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=803beaaa-33f9-48cc-9a95-c2e887e095b4#nlm34090-1"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=803beaaa-33f9-48cc-9a95-c2e887e095b4#nlm34090-1"]}, {"gene_symbol": "BRAF", "therapy_name": "Encorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DOI", "PubMed"], "ref_ids": ["10.1158/1538-7445.AM2012-3790", "23617957"], "ref_urls": ["http://cancerres.aacrjournals.org/content/72/8_Supplement/3790", "http://europepmc.org/abstract/MED/23617957"]}, {"gene_symbol": "BRAF", "therapy_name": "Pan-RAF Inhibitor LY3009120", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["25965804"], "ref_urls": ["http://europepmc.org/abstract/MED/25965804"]}, {"gene_symbol": "BRAF", "therapy_name": "Regorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Sorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "TRK Inhibitor", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Tovorafenib", "targets_moa": "RAF serine/threonine protein kinase inhibitor", "ref_sources": ["Other", "Other", "PubMed"], "ref_ids": ["http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=710688", "http://www.sunesis.com/products-in-development/product/MLN2480.php", "5653214"], "ref_urls": ["http://europepmc.org/abstract/MED/5653214", "http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=710688", "http://www.sunesis.com/products-in-development/product/MLN2480.php"]}, {"gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/202429s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202429s000lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Agerafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["http://ignyta.com/wp-content/uploads/2015/11/ENA-2015-poster-RXDX-105.pdf", "http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf"], "ref_urls": ["http://ignyta.com/wp-content/uploads/2015/11/ENA-2015-poster-RXDX-105.pdf", "http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "BRAF Inhibitor", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DOI", "PubMed"], "ref_ids": ["10.1158/1538-7445.AM2012-3790", "23617957"], "ref_urls": ["http://cancerres.aacrjournals.org/content/72/8_Supplement/3790", "http://europepmc.org/abstract/MED/23617957"]}, {"gene_symbol": "BRAF", "therapy_name": "Belvarafenib", "targets_moa": "RAF serine/threonine protein kinase inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["https://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.2570", "https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.3000"], "ref_urls": ["https://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.2570", "https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.3000"]}, {"gene_symbol": "BRAF", "therapy_name": "Dabrafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=803beaaa-33f9-48cc-9a95-c2e887e095b4#nlm34090-1"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=803beaaa-33f9-48cc-9a95-c2e887e095b4#nlm34090-1"]}, {"gene_symbol": "BRAF", "therapy_name": "Encorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DOI", "PubMed"], "ref_ids": ["10.1158/1538-7445.AM2012-3790", "23617957"], "ref_urls": ["http://cancerres.aacrjournals.org/content/72/8_Supplement/3790", "http://europepmc.org/abstract/MED/23617957"]}, {"gene_symbol": "BRAF", "therapy_name": "Pan-RAF Inhibitor LY3009120", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["25965804"], "ref_urls": ["http://europepmc.org/abstract/MED/25965804"]}, {"gene_symbol": "BRAF", "therapy_name": "Regorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Sorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "TRK Inhibitor", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Tovorafenib", "targets_moa": "RAF serine/threonine protein kinase inhibitor", "ref_sources": ["Other", "Other", "PubMed"], "ref_ids": ["http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=710688", "http://www.sunesis.com/products-in-development/product/MLN2480.php", "5653214"], "ref_urls": ["http://europepmc.org/abstract/MED/5653214", "http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=710688", "http://www.sunesis.com/products-in-development/product/MLN2480.php"]}, {"gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/202429s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202429s000lbl.pdf"]}, {"gene_symbol": "ERBB3", "therapy_name": "Duligotuzumab", "targets_moa": "Receptor tyrosine-protein kinase erbB-3 inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["27843803"], "ref_urls": ["http://europepmc.org/abstract/MED/27843803"]}, {"gene_symbol": "ERBB3", "therapy_name": "ERBB3 Inhibitor", "targets_moa": "Epidermal growth factor receptor inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13"]}, {"gene_symbol": "ERBB3", "therapy_name": "Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor", "targets_moa": "Epidermal growth factor receptor inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13"]}, {"gene_symbol": "ERBB3", "therapy_name": "Lumretuzumab", "targets_moa": "Receptor tyrosine-protein kinase erbB-3 inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["23780344", "26463709"], "ref_urls": ["http://europepmc.org/abstract/MED/23780344", "http://europepmc.org/abstract/MED/26463709"]}, {"gene_symbol": "ERBB3", "therapy_name": "Patritumab", "targets_moa": "Receptor tyrosine-protein kinase erbB-3 inhibitor", "ref_sources": ["nan"], "ref_ids": ["nan"], "ref_urls": ["nan"]}, {"gene_symbol": "ERBB3", "therapy_name": "Poziotinib", "targets_moa": "Epidermal growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["21306821"], "ref_urls": ["http://europepmc.org/abstract/MED/21306821"]}, {"gene_symbol": "ERBB3", "therapy_name": "Seribantumab", "targets_moa": "Receptor tyrosine-protein kinase erbB-3 inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=613844", "26310543"], "ref_urls": ["http://europepmc.org/abstract/MED/26310543", "https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=613844"]}, {"gene_symbol": "ERBB3", "therapy_name": "Tarloxotinib", "targets_moa": "Epidermal growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["33355298"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/33355298/"]}, {"gene_symbol": "ERBB3", "therapy_name": "Vandetanib", "targets_moa": "Epidermal growth factor receptor inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13"]}, {"gene_symbol": "MAP2K2", "therapy_name": "Binimetinib", "targets_moa": "Dual specificity mitogen-activated protein kinase kinase 2 inhibitor", "ref_sources": ["Other", "Other", "PubMed"], "ref_ids": ["http://arraybiopharma.com/files/4813/9810/8023/PubAttachment490.pdf", "http://arraybiopharma.com/product-pipeline/binimetinib/", "23414587"], "ref_urls": ["http://arraybiopharma.com/files/4813/9810/8023/PubAttachment490.pdf", "http://arraybiopharma.com/product-pipeline/binimetinib/", "http://europepmc.org/abstract/MED/23414587"]}, {"gene_symbol": "MAP2K2", "therapy_name": "Cobimetinib", "targets_moa": "Dual specificity mitogen-activated protein kinase kinase 2 inhibitor", "ref_sources": ["DailyMed", "PubMed", "PubMed"], "ref_ids": ["setid=c387579e-cee0-4334-bd1e-73f93ac1bde6", "22084396", "22496205"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c387579e-cee0-4334-bd1e-73f93ac1bde6", "http://europepmc.org/abstract/MED/22084396", "http://europepmc.org/abstract/MED/22496205"]}, {"gene_symbol": "MAP2K2", "therapy_name": "MEK Inhibitor CI-1040", "targets_moa": "Dual specificity mitogen-activated protein kinase kinase 2 inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["10395327", "16009947"], "ref_urls": ["http://europepmc.org/abstract/MED/10395327", "http://europepmc.org/abstract/MED/16009947"]}, {"gene_symbol": "MAP2K2", "therapy_name": "MEK Inhibitor GDC-0623", "targets_moa": "Dual specificity mitogen-activated protein kinase kinase 2 inhibitor", "ref_sources": ["DailyMed", "PubMed", "PubMed"], "ref_ids": ["setid=c387579e-cee0-4334-bd1e-73f93ac1bde6", "22084396", "22496205"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c387579e-cee0-4334-bd1e-73f93ac1bde6", "http://europepmc.org/abstract/MED/22084396", "http://europepmc.org/abstract/MED/22496205"]}, {"gene_symbol": "MAP2K2", "therapy_name": "MEK Inhibitor RO4987655", "targets_moa": "Dual specificity mitogen-activated protein kinase kinase 2 inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://cancerres.aacrjournals.org/content/69/9_Supplement/3701.abstract", "19934286", "23587417"], "ref_urls": ["http://cancerres.aacrjournals.org/content/69/9_Supplement/3701.abstract", "http://europepmc.org/abstract/MED/19934286", "http://europepmc.org/abstract/MED/23587417"]}, {"gene_symbol": "MAP2K2", "therapy_name": "Mirdametinib", "targets_moa": "Dual specificity mitogen-activated protein kinase kinase 2 inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://cancerres.aacrjournals.org/content/64/7_Supplement/925.1", "15573115"], "ref_urls": ["http://cancerres.aacrjournals.org/content/64/7_Supplement/925.1", "http://europepmc.org/abstract/MED/15573115"]}, {"gene_symbol": "MAP2K2", "therapy_name": "RDEA 119", "targets_moa": "Dual specificity mitogen-activated protein kinase kinase 2 inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["19706763"], "ref_urls": ["http://europepmc.org/abstract/MED/19706763"]}, {"gene_symbol": "MAP2K2", "therapy_name": "Refametinib", "targets_moa": "Dual specificity mitogen-activated protein kinase kinase 2 inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["19706763"], "ref_urls": ["http://europepmc.org/abstract/MED/19706763"]}, {"gene_symbol": "MAP2K2", "therapy_name": "Selumetinib", "targets_moa": "Dual specificity mitogen-activated protein kinase kinase 2 inhibitor | Dual specificity mitogen-activated protein kinase kinase; MEK1/2 inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2020/213756s000lbl.pdf", "17332304", "17699718"], "ref_urls": ["http://europepmc.org/abstract/MED/17332304", "http://europepmc.org/abstract/MED/17699718", "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213756s000lbl.pdf"]}, {"gene_symbol": "MET", "therapy_name": "Amivantamab", "targets_moa": "Hepatocyte growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["32414908"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/32414908/"]}, {"gene_symbol": "MET", "therapy_name": "Amuvatinib", "targets_moa": "Hepatocyte growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://www.google.com/patents/US20080226747", "24326130", "25110867"], "ref_urls": ["http://europepmc.org/abstract/MED/24326130", "http://europepmc.org/abstract/MED/25110867", "http://www.google.com/patents/US20080226747"]}, {"gene_symbol": "MET", "therapy_name": "C-Met Inhibitor", "targets_moa": "Hepatocyte growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "MET", "therapy_name": "Cabozantinib", "targets_moa": "Hepatocyte growth factor receptor inhibitor", "ref_sources": ["DailyMed", "PubMed", "PubMed"], "ref_ids": ["setid=1a0c3bea-c87b-4d25-bb44-5f0174da6b34", "21926191", "23104465"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a0c3bea-c87b-4d25-bb44-5f0174da6b34", "http://europepmc.org/abstract/MED/21926191", "http://europepmc.org/abstract/MED/23104465"]}, {"gene_symbol": "MET", "therapy_name": "Capmatinib", "targets_moa": "Hepatocyte growth factor receptor inhibitor", "ref_sources": ["FDA", "Other", "Other", "Other"], "ref_ids": ["label/2020/213591s000lbl.pdf", "http://cancerres.aacrjournals.org/content/68/9_Supplement/2577", "http://clincancerres.aacrjournals.org/content/early/2011/09/14/1078-0432.CCR-11-1157.full.pdf", "http://www.novartisoncology.com/ct/pipelineDetails?compound=INC280&diseaseAcr=NSCLC"], "ref_urls": ["http://cancerres.aacrjournals.org/content/68/9_Supplement/2577", "http://clincancerres.aacrjournals.org/content/early/2011/09/14/1078-0432.CCR-11-1157.full.pdf", "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213591s000lbl.pdf", "http://www.novartisoncology.com/ct/pipelineDetails?compound=INC280&diseaseAcr=NSCLC"]}, {"gene_symbol": "MET", "therapy_name": "Crizotinib", "targets_moa": "Hepatocyte growth factor receptor inhibitor", "ref_sources": ["FDA", "FDA"], "ref_ids": ["label/2012/202570s003lbl.pdf", "label/2017/202570s021lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202570s003lbl.pdf", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202570s021lbl.pdf"]}, {"gene_symbol": "MET", "therapy_name": "Foretinib", "targets_moa": "Hepatocyte growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "MET", "therapy_name": "MET Tyrosine Kinase Inhibitor SGX523", "targets_moa": "Hepatocyte growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["19934279", "25806189"], "ref_urls": ["http://europepmc.org/abstract/MED/19934279", "http://europepmc.org/abstract/MED/25806189"]}, {"gene_symbol": "MET", "therapy_name": "Ningetinib", "targets_moa": "Hepatocyte growth factor receptor inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.9583", "https://cancerres.aacrjournals.org/content/74/19_Supplement/1755"], "ref_urls": ["https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.9583", "https://cancerres.aacrjournals.org/content/74/19_Supplement/1755"]}, {"gene_symbol": "MET", "therapy_name": "Onartuzumab", "targets_moa": "Hepatocyte growth factor receptor antagonist", "ref_sources": ["PubMed"], "ref_ids": ["23882082"], "ref_urls": ["http://europepmc.org/abstract/MED/23882082"]}, {"gene_symbol": "MET", "therapy_name": "Savolitinib", "targets_moa": "Hepatocyte growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["25148209", "25779944"], "ref_urls": ["http://europepmc.org/abstract/MED/25148209", "http://europepmc.org/abstract/MED/25779944"]}, {"gene_symbol": "MET", "therapy_name": "Tepotinib", "targets_moa": "Hepatocyte growth factor receptor inhibitor", "ref_sources": ["PMDA", "PubMed", "PubMed", "PubMed"], "ref_ids": ["https://www.pmda.go.jp/files/000235289.pdf", "23553846", "25110867", "31822497"], "ref_urls": ["http://europepmc.org/abstract/MED/23553846", "http://europepmc.org/abstract/MED/25110867", "http://europepmc.org/abstract/MED/31822497", "https://www.pmda.go.jp/files/000235289.pdf"]}, {"gene_symbol": "NRAS", "therapy_name": "Salirasib", "targets_moa": "RAS inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["22547163"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/22547163/"]}], "generated_rows": [], "error": null}
{"id": "F1.3-000056-P3", "question": "Identify the gene for the variant VHL Deletion AND R69C (c.205C>T).", "gold_cypher": "MATCH (v:Variant {name: 'VHL Deletion AND R69C (c.205C>T)'})-[:VARIANT_OF]->(g:Gene)\nRETURN g.symbol AS gene_symbol, v.name AS variant_name\nLIMIT 100\n", "generated_cypher": "MATCH (v:Variant)-[:VARIANT_OF]->(g:Gene)\nWHERE (\n    (toLower(v.name) = toLower('VHL Deletion'))\n    OR (\n        toLower(v.name) CONTAINS toLower('deletion')\n        AND (\n            toLower(g.symbol) = toLower('VHL')\n            OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('VHL'))\n        )\n    )\n)\nOR (\n    (toLower(v.name) = toLower('R69C (c.205C>T)'))\n    OR (v.hgvs_p = 'p.R69C')\n    OR (toLower(v.name) CONTAINS toLower('R69C'))\n    OR (toLower(v.name) CONTAINS toLower('c.205C>T'))\n)\nRETURN v.name AS variant_name, g.symbol AS gene_symbol\nLIMIT 100", "gold_rows": [{"gene_symbol": "VHL", "variant_name": "VHL Deletion AND R69C (c.205C>T)"}], "generated_rows": [{"variant_name": "VHL 10kb Deletion", "gene_symbol": "VHL"}, {"variant_name": "VHL 2kb Deletion", "gene_symbol": "VHL"}, {"variant_name": "VHL 5kb Deletion", "gene_symbol": "VHL"}, {"variant_name": "VHL Deletion", "gene_symbol": "VHL"}, {"variant_name": "VHL Deletion AND I151S(c.452T>G)", "gene_symbol": "VHL"}, {"variant_name": "VHL Deletion AND R200W (c.598C>T)", "gene_symbol": "VHL"}, {"variant_name": "VHL Deletion AND R69C (c.205C>T)", "gene_symbol": "VHL"}, {"variant_name": "VHL EXON 1-2 DELETION and BRK1 DELETION", "gene_symbol": "VHL"}, {"variant_name": "VHL EXON 2-3 DELETION", "gene_symbol": "VHL"}, {"variant_name": "VHL Exon 1 Deletion", "gene_symbol": "VHL"}, {"variant_name": "VHL Exon 1-2 Deletion", "gene_symbol": "VHL"}, {"variant_name": "VHL Exon 1-3 Deletion", "gene_symbol": "VHL"}, {"variant_name": "VHL Exon 1-3 Deletion and Splice Region (c.340+5G>C)", "gene_symbol": "VHL"}, {"variant_name": "VHL Exon 2 Deletion", "gene_symbol": "VHL"}, {"variant_name": "VHL Exon 2-3 Deletion", "gene_symbol": "VHL"}, {"variant_name": "VHL Exon 3 Deletion", "gene_symbol": "VHL"}, {"variant_name": "VHL Exon 3 Deletion AND VHL S139C (c.416C>G)", "gene_symbol": "VHL"}, {"variant_name": "VHL Exon 3 deletion (c.464-11 T>A)", "gene_symbol": "VHL"}, {"variant_name": "VHL Exon Deletion", "gene_symbol": "VHL"}, {"variant_name": "VHL Intronic deletion (c.341-13delCGTTTCCAACAATTTCTCGGTGT)", "gene_symbol": "VHL"}, {"variant_name": "VHL Null (11 kb 3' deletion)", "gene_symbol": "VHL"}, {"variant_name": "VHL Null (Complete deletion)", "gene_symbol": "VHL"}, {"variant_name": "VHL Null (Large deletion)", "gene_symbol": "VHL"}, {"variant_name": "VHL Null (Partial deletion of 4.6 Kb)", "gene_symbol": "VHL"}, {"variant_name": "VHL Null (Partial deletion of Exon 1)", "gene_symbol": "VHL"}, {"variant_name": "VHL Null (Partial deletion of Exon 2)", "gene_symbol": "VHL"}, {"variant_name": "VHL Null (Partial deletion of Exon 3)", "gene_symbol": "VHL"}, {"variant_name": "VHL Null (Partial deletion of Exons 1 & 2)", "gene_symbol": "VHL"}, {"variant_name": "VHL Null (Partial deletion of Exons 2 & 3)", "gene_symbol": "VHL"}, {"variant_name": "VHL Null (Partial deletion)", "gene_symbol": "VHL"}, {"variant_name": "VHL Null (deletion)", "gene_symbol": "VHL"}, {"variant_name": "VHL Null (large 3' deletion)", "gene_symbol": "VHL"}, {"variant_name": "VHL Partial Deletion and P61=( c.183C>G)", "gene_symbol": "VHL"}, {"variant_name": "VHL Partial deletion of 0.7 Kb", "gene_symbol": "VHL"}, {"variant_name": "VHL Partial deletion of 0.8 kb", "gene_symbol": "VHL"}, {"variant_name": "VHL Partial deletion of 1 Kb", "gene_symbol": "VHL"}, {"variant_name": "VHL Partial deletion of 1.2 Kb", "gene_symbol": "VHL"}, {"variant_name": "VHL Partial deletion of 1.5 Kb", "gene_symbol": "VHL"}, {"variant_name": "VHL Partial deletion of 10 Kb", "gene_symbol": "VHL"}, {"variant_name": "VHL Partial deletion of 11 Kb", "gene_symbol": "VHL"}, {"variant_name": "VHL Partial deletion of 12 Kb", "gene_symbol": "VHL"}, {"variant_name": "VHL Partial deletion of 2 Kb", "gene_symbol": "VHL"}, {"variant_name": "VHL Partial deletion of 3 Kb", "gene_symbol": "VHL"}, {"variant_name": "VHL Partial deletion of 3.5 Kb", "gene_symbol": "VHL"}, {"variant_name": "VHL Partial deletion of 4 Kb", "gene_symbol": "VHL"}, {"variant_name": "VHL Partial deletion of 7 Kb", "gene_symbol": "VHL"}, {"variant_name": "VHL Partial deletion of 7.5 Kb", "gene_symbol": "VHL"}, {"variant_name": "VHL Partial deletion of 8.2 Kb", "gene_symbol": "VHL"}, {"variant_name": "VHL Single Allele Deletion", "gene_symbol": "VHL"}], "error": null}
{"id": "F1.3-000062-P2", "question": "BRCA1 Mutation OR BRCA2 Mutation is a variant of what gene?", "gold_cypher": "MATCH (v:Variant {name: 'BRCA1 Mutation OR BRCA2 Mutation'})-[:VARIANT_OF]->(g:Gene)\nRETURN g.symbol AS gene_symbol, v.name AS variant_name\nLIMIT 100\n", "generated_cypher": "MATCH (v:Variant)-[:VARIANT_OF]->(g:Gene)\nWHERE toLower(v.name) = toLower('BRCA1 Mutation')\n   OR toLower(v.name) = toLower('BRCA2 Mutation')\nRETURN v.name AS variant_name, g.symbol AS gene_symbol\nLIMIT 100", "gold_rows": [{"gene_symbol": "BRCA1", "variant_name": "BRCA1 Mutation OR BRCA2 Mutation"}], "generated_rows": [{"variant_name": "BRCA1 Mutation", "gene_symbol": "BRCA1"}, {"variant_name": "BRCA2 Mutation", "gene_symbol": "BRCA2"}], "error": null}
{"id": "F2.2-000158-S1-P1", "question": "What is the effect of IDH2 Mutation on Venetoclax in Acute Myelogenous Leukaemia?", "gold_cypher": "MATCH (v:Variant {name: 'IDH2 Mutation'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Venetoclax')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Venetoclax'))\n  OR toLower(t.name) CONTAINS toLower('Venetoclax')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'acute' AND\n    toLower(rel.disease_name) CONTAINS 'myeloid' AND\n    toLower(rel.disease_name) CONTAINS 'leukemia'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Venetoclax')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Venetoclax'))\n  OR toLower(t.name) CONTAINS toLower('Venetoclax')\n)\nAND b:Variant\nMATCH (b)-[:VARIANT_OF]->(g:Gene)\nWHERE (\n  toLower(g.symbol) = toLower('IDH2')\n  OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('IDH2'))\n)\nAND toLower(b.name) CONTAINS toLower('mutation')\nAND toLower(rel.disease_name) CONTAINS toLower('acute')\nAND toLower(rel.disease_name) CONTAINS toLower('myelogenous')\nAND toLower(rel.disease_name) CONTAINS toLower('leukemia')\nRETURN\n  coalesce(b.name, b.hgvs_p) AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "IDH2 Mutation", "gene_symbol": "IDH2", "therapy_name": "Venetoclax", "effect": "sensitivity", "disease_name": "Acute Myeloid Leukemia", "pmids": ["30725494"]}], "generated_rows": [], "error": null}
{"id": "F2.2-000172-S2-P3", "question": "How does EGFR VIII influence response to Pacritinib for Adult Glioblastoma Multiforme?", "gold_cypher": "MATCH (v:Variant {name: 'EGFR VIII'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Pacritinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Pacritinib'))\n  OR toLower(t.name) CONTAINS toLower('Pacritinib')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'glioblastoma'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (v:Variant)\nWHERE toLower(v.name) = toLower('EGFR VIII')\n   OR toLower(v.name) CONTAINS toLower('EGFR VIII')\nMATCH (v)-[:VARIANT_OF]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('EGFR')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('EGFR'))\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(t.name) = toLower('Pacritinib')\n    OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Pacritinib'))\n    OR toLower(t.name) CONTAINS toLower('Pacritinib')\n)\nAND toLower(rel.disease_name) CONTAINS toLower('glioblastoma')\nAND toLower(rel.disease_name) CONTAINS toLower('multiforme')\nRETURN\n    v.name AS variant_name,\n    g.symbol AS gene_symbol,\n    t.name AS therapy_name,\n    rel.effect AS effect,\n    rel.disease_name AS disease_name,\n    coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Pacritinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}], "generated_rows": [], "error": null}
{"id": "F4.2-000199-S2-P2", "question": "Which drugs target biomarkers of resistance to Selpercatinib in Non-small Cell Lung Carcinoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Selpercatinib')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Selpercatinib'))\n  OR toLower(t1.name) CONTAINS toLower('Selpercatinib')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Selpercatinib')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (t_initial:Therapy)\nWHERE toLower(t_initial.name) = toLower('Selpercatinib')\n   OR any(s IN coalesce(t_initial.synonyms, []) WHERE toLower(s) = toLower('Selpercatinib'))\n   OR toLower(t_initial.name) CONTAINS toLower('Selpercatinib')\n\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t_initial)\nWHERE toLower(rel.effect) = 'resistance'\n  AND toLower(rel.disease_name) CONTAINS toLower('lung')\n  AND toLower(rel.disease_name) CONTAINS toLower('non-small')\n  AND toLower(rel.disease_name) CONTAINS toLower('cell')\n  AND toLower(rel.disease_name) CONTAINS toLower('carcinoma')\n\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g_variant:Gene)\n\nWITH b, rel, t_initial, g_variant,\n     CASE WHEN b:Gene THEN b ELSE g_variant END AS g_biomarker_node,\n     CASE WHEN b:Gene THEN b.symbol ELSE g_variant.symbol END AS gene_symbol_biomarker\n\nWHERE gene_symbol_biomarker IS NOT NULL\n\nMATCH (t_targeting:Therapy)-[r:TARGETS]->(g_biomarker_node)\n\nRETURN\n  NULL AS variant_name,\n  gene_symbol_biomarker AS gene_symbol,\n  t_targeting.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100", "gold_rows": [{"gene_symbol": "KIF5B", "therapy_name": "Pralsetinib", "targets_moa": "Kinesin-1 heavy chain/ Tyrosine-protein kinase receptor RET inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213721s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213721s000lbl.pdf"]}, {"gene_symbol": "KIF5B", "therapy_name": "Pralsetinib", "targets_moa": "Kinesin-1 heavy chain/ Tyrosine-protein kinase receptor RET inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213721s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213721s000lbl.pdf"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "KIF5B", "therapy_name": "Pralsetinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31988000"], "targets_moa": "Kinesin-1 heavy chain/ Tyrosine-protein kinase receptor RET inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213721s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213721s000lbl.pdf"]}, {"variant_name": null, "gene_symbol": "KIF5B", "therapy_name": "Selpercatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31988000"], "targets_moa": "Kinesin-1 heavy chain/ Tyrosine-protein kinase receptor RET inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213246s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213246s000lbl.pdf"]}, {"variant_name": null, "gene_symbol": "KIF5B", "therapy_name": "Pralsetinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31988000"], "targets_moa": "Kinesin-1 heavy chain/ Tyrosine-protein kinase receptor RET inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213721s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213721s000lbl.pdf"]}, {"variant_name": null, "gene_symbol": "KIF5B", "therapy_name": "Selpercatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31988000"], "targets_moa": "Kinesin-1 heavy chain/ Tyrosine-protein kinase receptor RET inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213246s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213246s000lbl.pdf"]}], "error": null}
{"id": "F1.2-000039-P4", "question": "What genes does Elacestrant affect?", "gold_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(t.name) = toLower('Elacestrant')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Elacestrant'))\n  OR toLower(t.name) CONTAINS toLower('Elacestrant')\n)\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (t:Therapy)\nWHERE (\n    toLower(t.name) = toLower('Elacestrant')\n    OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Elacestrant'))\n    OR toLower(t.name) CONTAINS toLower('Elacestrant')\n)\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n    CASE\n        WHEN b:Gene THEN b.symbol\n        WHEN b:Variant THEN g.symbol\n        ELSE NULL\n    END AS gene_symbol,\n    t.name AS therapy_name,\n    rel.effect AS effect,\n    rel.disease_name AS disease_name,\n    coalesce(rel.pmids, []) AS pmids_list\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids_list AS p\nWITH gene_symbol, therapy_name, effect, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n    NULL AS variant_name,\n    gene_symbol,\n    therapy_name,\n    effect,\n    disease_name,\n    pmids\nLIMIT 100", "gold_rows": [{"gene_symbol": "ESR1", "therapy_name": "Elacestrant", "targets_moa": "Estrogen receptor alpha degrader", "ref_sources": ["FDA", "Other", "Other", "PubMed"], "ref_ids": ["label/2023/217639s000lbl.pdf", "http://ir.radiuspharm.com/releasedetail.cfm?ReleaseID=888510", "http://www.radiuspharm.com/index.php/r-d/pipeline.html", "26164151"], "ref_urls": ["http://europepmc.org/abstract/MED/26164151", "http://ir.radiuspharm.com/releasedetail.cfm?ReleaseID=888510", "http://www.radiuspharm.com/index.php/r-d/pipeline.html", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217639s000lbl.pdf"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "ESR1", "therapy_name": "Elacestrant", "effect": "sensitivity", "disease_name": "Estrogen-receptor Positive Breast Cancer", "pmids": ["35584336"]}, {"variant_name": null, "gene_symbol": "ESR1", "therapy_name": "Elacestrant", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["35584336"]}], "error": null}
{"id": "F3.2-000111", "question": "What therapies target both HDAC1 and HDAC3?", "gold_cypher": "MATCH (t:Therapy)-[r1:TARGETS]->(g1:Gene)\nWHERE toLower(g1.symbol) = toLower('HDAC1')\n   OR any(s IN coalesce(g1.synonyms, []) WHERE toLower(s) = toLower('HDAC1'))\nMATCH (t)-[r2:TARGETS]->(g2:Gene)\nWHERE toLower(g2.symbol) = toLower('HDAC3')\n   OR any(s IN coalesce(g2.synonyms, []) WHERE toLower(s) = toLower('HDAC3'))\nWITH t, g1, r1, g2, r2\nUNWIND [\n  {gene: g1, rel: r1},\n  {gene: g2, rel: r2}\n] AS pair\nRETURN\n  pair.gene.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  pair.rel.moa AS targets_moa,\n  coalesce(pair.rel.ref_sources, []) AS ref_sources,\n  coalesce(pair.rel.ref_ids, []) AS ref_ids,\n  coalesce(pair.rel.ref_urls, []) AS ref_urls\nLIMIT 100\n", "generated_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (toLower(g.symbol) = toLower('HDAC1') OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('HDAC1')))\n   OR (toLower(g.symbol) = toLower('HDAC3') OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('HDAC3')))\nWITH\n  t.name AS therapy_name,\n  collect(DISTINCT g.symbol) AS targeted_genes,\n  collect(DISTINCT r.moa) AS targets_moas,\n  collect(coalesce(r.ref_sources, [])) AS all_ref_sources,\n  collect(coalesce(r.ref_ids, [])) AS all_ref_ids,\n  collect(coalesce(r.ref_urls, [])) AS all_ref_urls\nWHERE 'HDAC1' IN targeted_genes AND 'HDAC3' IN targeted_genes\nRETURN\n  NULL AS variant_name,\n  therapy_name,\n  targeted_genes AS gene_symbol,\n  targets_moas AS targets_moa,\n  all_ref_sources AS ref_sources,\n  all_ref_ids AS ref_ids,\n  all_ref_urls AS ref_urls\nLIMIT 100", "gold_rows": [{"gene_symbol": "HDAC1", "therapy_name": "Abexinostat", "targets_moa": "Histone deacetylase inhibitor", "ref_sources": ["PubMed", "PubMed", "PubMed"], "ref_ids": ["16731764", "20145726", "25520806"], "ref_urls": ["http://europepmc.org/abstract/MED/16731764", "http://europepmc.org/abstract/MED/20145726", "http://europepmc.org/abstract/MED/25520806"]}, {"gene_symbol": "HDAC3", "therapy_name": "Abexinostat", "targets_moa": "Histone deacetylase inhibitor", "ref_sources": ["PubMed", "PubMed", "PubMed"], "ref_ids": ["16731764", "20145726", "25520806"], "ref_urls": ["http://europepmc.org/abstract/MED/16731764", "http://europepmc.org/abstract/MED/20145726", "http://europepmc.org/abstract/MED/25520806"]}, {"gene_symbol": "HDAC1", "therapy_name": "Belinostat", "targets_moa": "Histone deacetylase inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2014/206256lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206256lbl.pdf"]}, {"gene_symbol": "HDAC3", "therapy_name": "Belinostat", "targets_moa": "Histone deacetylase inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2014/206256lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206256lbl.pdf"]}, {"gene_symbol": "HDAC1", "therapy_name": "Mocetinostat", "targets_moa": "Histone deacetylase 1 inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["18413790", "27551526"], "ref_urls": ["http://europepmc.org/abstract/MED/18413790", "http://europepmc.org/abstract/MED/27551526"]}, {"gene_symbol": "HDAC3", "therapy_name": "Mocetinostat", "targets_moa": "Histone deacetylase 3 inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["18413790", "27551526"], "ref_urls": ["http://europepmc.org/abstract/MED/18413790", "http://europepmc.org/abstract/MED/27551526"]}, {"gene_symbol": "HDAC1", "therapy_name": "Panobinostat", "targets_moa": "Histone deacetylase inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2015/205353s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205353s000lbl.pdf"]}, {"gene_symbol": "HDAC3", "therapy_name": "Panobinostat", "targets_moa": "Histone deacetylase inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2015/205353s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205353s000lbl.pdf"]}, {"gene_symbol": "HDAC1", "therapy_name": "Vorinostat", "targets_moa": "Histone deacetylase 1 inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13"]}, {"gene_symbol": "HDAC3", "therapy_name": "Vorinostat", "targets_moa": "Histone deacetylase 3 inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13"]}], "generated_rows": [{"variant_name": null, "therapy_name": "Abexinostat", "gene_symbol": ["HDAC1", "HDAC3"], "targets_moa": ["Histone deacetylase inhibitor"], "ref_sources": [["PubMed", "PubMed", "PubMed"], ["PubMed", "PubMed", "PubMed"]], "ref_ids": [["16731764", "20145726", "25520806"], ["16731764", "20145726", "25520806"]], "ref_urls": [["http://europepmc.org/abstract/MED/16731764", "http://europepmc.org/abstract/MED/20145726", "http://europepmc.org/abstract/MED/25520806"], ["http://europepmc.org/abstract/MED/16731764", "http://europepmc.org/abstract/MED/20145726", "http://europepmc.org/abstract/MED/25520806"]]}, {"variant_name": null, "therapy_name": "Belinostat", "gene_symbol": ["HDAC1", "HDAC3"], "targets_moa": ["Histone deacetylase inhibitor"], "ref_sources": [["FDA"], ["FDA"]], "ref_ids": [["label/2014/206256lbl.pdf"], ["label/2014/206256lbl.pdf"]], "ref_urls": [["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206256lbl.pdf"], ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206256lbl.pdf"]]}, {"variant_name": null, "therapy_name": "Mocetinostat", "gene_symbol": ["HDAC1", "HDAC3"], "targets_moa": ["Histone deacetylase 1 inhibitor", "Histone deacetylase 3 inhibitor"], "ref_sources": [["PubMed", "PubMed"], ["PubMed", "PubMed"]], "ref_ids": [["18413790", "27551526"], ["18413790", "27551526"]], "ref_urls": [["http://europepmc.org/abstract/MED/18413790", "http://europepmc.org/abstract/MED/27551526"], ["http://europepmc.org/abstract/MED/18413790", "http://europepmc.org/abstract/MED/27551526"]]}, {"variant_name": null, "therapy_name": "Panobinostat", "gene_symbol": ["HDAC1", "HDAC3"], "targets_moa": ["Histone deacetylase inhibitor"], "ref_sources": [["FDA"], ["FDA"]], "ref_ids": [["label/2015/205353s000lbl.pdf"], ["label/2015/205353s000lbl.pdf"]], "ref_urls": [["http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205353s000lbl.pdf"], ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205353s000lbl.pdf"]]}, {"variant_name": null, "therapy_name": "Vorinostat", "gene_symbol": ["HDAC1", "HDAC3"], "targets_moa": ["Histone deacetylase 1 inhibitor", "Histone deacetylase 3 inhibitor"], "ref_sources": [["DailyMed"], ["DailyMed"]], "ref_ids": [["setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13"], ["setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13"]], "ref_urls": [["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13"], ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13"]]}], "error": null}
{"id": "F6.3-000001-S2-P3", "question": "Show therapies for EGFR where variants cause resistance in Non-small Cell Lung Carcinoma.", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('EGFR')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('EGFR'))\nMATCH (v:Variant)-[:VARIANT_OF]->(g)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'resistance' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker:Variant)-[:VARIANT_OF]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('EGFR')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('EGFR'))\nMATCH (b)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE toLower(rel.effect) = 'resistance'\n  AND toLower(rel.disease_name) CONTAINS toLower('non-small')\n  AND toLower(rel.disease_name) CONTAINS toLower('cell')\n  AND toLower(rel.disease_name) CONTAINS toLower('lung')\n  AND toLower(rel.disease_name) CONTAINS toLower('carcinoma')\nRETURN\n  CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) END AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "EGFR Mutation", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25948633"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24035188"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Dacomitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21430269"]}, {"variant_name": "EGFR A767_V769dupASV", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21132006"]}, {"variant_name": "EGFR A859T", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["17877814"]}, {"variant_name": "EGFR D761Y", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["17085664"]}, {"variant_name": "EGFR D770_N771insNPG", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR D770_N771insSVD", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160", "17877814"]}, {"variant_name": "EGFR H773_V774insH", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR M766_A767insAI", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR N771delinsGY", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21132006"]}, {"variant_name": "EGFR N826S", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["19147750"]}, {"variant_name": "EGFR P772_H773insH", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR P772_H773insYNP", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR P848L", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["17877814"]}, {"variant_name": "EGFR S768N", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["19786660", "21132006"]}, {"variant_name": "EGFR S784F", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21841502"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25668228", "27304188", "15737014", "21132006"]}, {"variant_name": "EGFR V769_D770insASV", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR Y764_V765insHH", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR D761Y", "gene_symbol": "EGFR", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["17085664"]}, {"variant_name": "EGFR Mutation", "gene_symbol": "EGFR", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25948633"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["15728811", "17020982", "15737014"]}, {"variant_name": "EGFR Wildtype", "gene_symbol": "EGFR", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["19692680"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Lapatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["18408761"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Naquotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29386539"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28202511"]}, {"variant_name": "EGFR C797S", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25939061"]}, {"variant_name": "EGFR M766Q", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31254668"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29386539"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Rociletinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28202511"]}], "generated_rows": [{"variant_name": "EGFR A767_V769dupASV", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21132006"]}, {"variant_name": "EGFR A859T", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["17877814"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28202511"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Rociletinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28202511"]}, {"variant_name": "EGFR C797S", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25939061"]}, {"variant_name": "EGFR D761Y", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["17085664"]}, {"variant_name": "EGFR D761Y", "gene_symbol": "EGFR", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["17085664"]}, {"variant_name": "EGFR D770_N771insNPG", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR D770_N771insSVD", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160", "17877814"]}, {"variant_name": "EGFR Exon 19 Deletion", "gene_symbol": "EGFR", "therapy_name": "Anti-PD-L1 Monoclonal Antibody", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31086949"]}, {"variant_name": "EGFR Exon 19 Deletion", "gene_symbol": "EGFR", "therapy_name": "Anti-PD1 Monoclonal Antibody", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31086949"]}, {"variant_name": "EGFR H773_V774insH", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR L858R", "gene_symbol": "EGFR", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099"]}, {"variant_name": "EGFR M766Q", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31254668"]}, {"variant_name": "EGFR M766_A767insAI", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR Mutation", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25948633"]}, {"variant_name": "EGFR Mutation", "gene_symbol": "EGFR", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25948633"]}, {"variant_name": "EGFR N771delinsGY", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21132006"]}, {"variant_name": "EGFR N826S", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["19147750"]}, {"variant_name": "EGFR P772_H773insH", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR P772_H773insYNP", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR P848L", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["17877814"]}, {"variant_name": "EGFR S768N", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["19786660", "21132006"]}, {"variant_name": "EGFR S784F", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21841502"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24035188"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Dacomitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21430269"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25668228", "27304188", "15737014", "21132006"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["15728811", "17020982", "15737014"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Lapatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["18408761"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Mitogen-Activated Protein Kinase Kinase Inhibitor", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29386539"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Naquotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29386539"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29386539"]}, {"variant_name": "EGFR V769_D770insASV", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR Wildtype", "gene_symbol": "EGFR", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["19692680"]}, {"variant_name": "EGFR Y764_V765insHH", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}], "error": null}
{"id": "F6.3-000186-P2", "question": "List drugs targeting PDGFRB with resistant variants in Acute Myeloid Leukemia.", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('PDGFRB')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('PDGFRB'))\nMATCH (v:Variant)-[:VARIANT_OF]->(g)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'acute' AND\n    toLower(rel.disease_name) CONTAINS 'myeloid' AND\n    toLower(rel.disease_name) CONTAINS 'leukemia'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'resistance' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('PDGFRB')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('PDGFRB'))\nMATCH (b:Biomarker:Variant)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.effect) = toLower('resistance')\n  AND toLower(rel.disease_name) CONTAINS toLower('acute')\n  AND toLower(rel.disease_name) CONTAINS toLower('myeloid')\n  AND toLower(rel.disease_name) CONTAINS toLower('leukemia')\nMATCH (b)-[:VARIANT_OF]->(gene_of_variant:Gene)\nRETURN\n  coalesce(b.name, b.hgvs_p) AS variant_name,\n  gene_of_variant.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [], "generated_rows": [{"variant_name": "BCR BCR::ABL1 Fusion", "gene_symbol": "BCR", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["12476305"]}, {"variant_name": "FGF2 EXPRESSION", "gene_symbol": "FGF2", "therapy_name": "Quizartinib", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["27671675"]}, {"variant_name": "FLT3 D835", "gene_symbol": "FLT3", "therapy_name": "Quizartinib", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["22504184", "23430109"]}, {"variant_name": "FLT3 D835", "gene_symbol": "FLT3", "therapy_name": "Sorafenib", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["22368270"]}, {"variant_name": "FLT3 D835H", "gene_symbol": "FLT3", "therapy_name": "Sorafenib", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["23969938"]}, {"variant_name": "FLT3 D835H/Y", "gene_symbol": "FLT3", "therapy_name": "Sorafenib", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["23969938"]}, {"variant_name": "FLT3 D835V", "gene_symbol": "FLT3", "therapy_name": "Tandutinib", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["15256420"]}, {"variant_name": "FLT3 F691L", "gene_symbol": "FLT3", "therapy_name": "Crenolanib", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["30651561"]}, {"variant_name": "FLT3 F691L", "gene_symbol": "FLT3", "therapy_name": "Midostaurin", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["22858906"]}, {"variant_name": "FLT3 F691L", "gene_symbol": "FLT3", "therapy_name": "Quizartinib", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["22504184", "22858906"]}, {"variant_name": "FLT3 F691L", "gene_symbol": "FLT3", "therapy_name": "Sorafenib", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["22858906"]}, {"variant_name": "FLT3 F691L", "gene_symbol": "FLT3", "therapy_name": "Sunitinib", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["22858906"]}, {"variant_name": "FLT3 G697R", "gene_symbol": "FLT3", "therapy_name": "Midostaurin", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["15374944"]}, {"variant_name": "FLT3 ITD  N676D", "gene_symbol": "FLT3", "therapy_name": "Sorafenib", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["24619500"]}, {"variant_name": "FLT3 ITD & D839G", "gene_symbol": "FLT3", "therapy_name": "Sorafenib", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["23430109"]}, {"variant_name": "FLT3 ITD & TKD MUTATIONS", "gene_symbol": "FLT3", "therapy_name": "Sorafenib", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["24619500"]}, {"variant_name": "FLT3 ITD & Y842C", "gene_symbol": "FLT3", "therapy_name": "Sorafenib", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["29773601"]}, {"variant_name": "FLT3 ITD AND FLT3 D835Y", "gene_symbol": "FLT3", "therapy_name": "Sorafenib", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["22368270"]}, {"variant_name": "FLT3 ITD D651G", "gene_symbol": "FLT3", "therapy_name": "Sorafenib", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["24619500"]}, {"variant_name": "FLT3 ITD I687F", "gene_symbol": "FLT3", "therapy_name": "Sorafenib", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["24619500"]}, {"variant_name": "FLT3 ITD N676K", "gene_symbol": "FLT3", "therapy_name": "Midostaurin", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["16150941"]}, {"variant_name": "FLT3 ITD&F691(I/L)", "gene_symbol": "FLT3", "therapy_name": "Quizartinib", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["22875611"]}, {"variant_name": "FLT3 TKD MUTATION", "gene_symbol": "FLT3", "therapy_name": "Sorafenib", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["18230792"]}, {"variant_name": "FLT3 Y842C", "gene_symbol": "FLT3", "therapy_name": "Quizartinib", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["22858906"]}, {"variant_name": "FLT3 Y842C", "gene_symbol": "FLT3", "therapy_name": "Sorafenib", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["22858906"]}, {"variant_name": "FLT3 Y842C", "gene_symbol": "FLT3", "therapy_name": "Sunitinib", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["22858906"]}, {"variant_name": "KIT D816H", "gene_symbol": "KIT", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["15650049"]}], "error": null}
{"id": "F2.2-000187-S1-P1", "question": "Which genes confer sensitivity to Ponatinib in Acute Myeloblastic Leukemia?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Ponatinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Ponatinib'))\n  OR toLower(t.name) CONTAINS toLower('Ponatinib')\n)\nAND toLower(rel.effect) = 'sensitivity'\nAND (\n    toLower(rel.disease_name) CONTAINS 'acute' AND\n    toLower(rel.disease_name) CONTAINS 'myeloid' AND\n    toLower(rel.disease_name) CONTAINS 'leukemia'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'sensitivity' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(t.name) = toLower('ponatinib')\n    OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('ponatinib'))\n    OR toLower(t.name) CONTAINS toLower('ponatinib')\n)\nAND toLower(rel.effect) = 'sensitivity'\nAND toLower(rel.disease_name) CONTAINS toLower('acute')\nAND toLower(rel.disease_name) CONTAINS toLower('myeloblastic')\nAND toLower(rel.disease_name) CONTAINS toLower('leukemia')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n    CASE\n        WHEN b:Gene THEN b.symbol\n        WHEN b:Variant THEN g.symbol\n        ELSE NULL\n    END AS gene_symbol,\n    t.name AS therapy_name,\n    rel.effect AS effect,\n    rel.disease_name AS disease_name,\n    coalesce(rel.pmids, []) AS pmids_list\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids_list AS p\nWITH gene_symbol, therapy_name, disease_name, effect, collect(DISTINCT p) AS pmids\nRETURN\n    NULL AS variant_name,\n    gene_symbol,\n    therapy_name,\n    effect,\n    disease_name,\n    pmids\nLIMIT 100", "gold_rows": [{"variant_name": null, "gene_symbol": "FGFR1OP2", "therapy_name": "Ponatinib", "effect": "sensitivity", "disease_name": "Acute Myeloid Leukemia", "pmids": ["21482694"]}, {"variant_name": null, "gene_symbol": "FIP1L1", "therapy_name": "Ponatinib", "effect": "sensitivity", "disease_name": "Acute Myeloid Leukemia", "pmids": ["21482694"]}, {"variant_name": null, "gene_symbol": "FLT3", "therapy_name": "Ponatinib", "effect": "sensitivity", "disease_name": "Acute Myeloid Leukemia", "pmids": ["33914060", "21482694", "23430109"]}, {"variant_name": null, "gene_symbol": "KIT", "therapy_name": "Ponatinib", "effect": "sensitivity", "disease_name": "Acute Myeloid Leukemia", "pmids": ["21482694"]}], "generated_rows": [], "error": null}
{"id": "F2.4-000097-P1", "question": "What consequence does the variant ERBB2 G776INSV_G/C have?", "gold_cypher": "MATCH (v:Variant {name: 'ERBB2 G776INSV_G/C'})\nRETURN\n  v.name AS variant_name,\n  v.consequence AS variant_consequence\nLIMIT 100\n", "generated_cypher": "MATCH (v:Variant)-[:VARIANT_OF]->(g:Gene)\nWHERE (toLower(g.symbol) = toLower('ERBB2') OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ERBB2')))\n  AND toLower(v.name) = toLower('ERBB2 G776INSV_G/C')\nRETURN v.name AS variant_name, g.symbol AS gene_symbol, v.consequence AS consequence\nLIMIT 100", "gold_rows": [{"variant_name": "ERBB2 G776INSV_G/C", "variant_consequence": null}], "generated_rows": [{"variant_name": "ERBB2 G776INSV_G/C", "gene_symbol": "ERBB2", "consequence": null}], "error": null}
{"id": "F2.4-000121-P3", "question": "What is the functional consequence of HRAS G13V?", "gold_cypher": "MATCH (v:Variant {name: 'HRAS G13V'})\nRETURN\n  v.name AS variant_name,\n  v.consequence AS variant_consequence\nLIMIT 100\n", "generated_cypher": "MATCH (v:Variant)-[:VARIANT_OF]->(g:Gene)\nWHERE (toLower(g.symbol) = toLower('HRAS') OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('HRAS')))\n  AND toLower(v.name) = toLower('HRAS G13V')\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  v.consequence AS consequence\nLIMIT 100", "gold_rows": [{"variant_name": "HRAS G13V", "variant_consequence": null}], "generated_rows": [{"variant_name": "HRAS G13V", "gene_symbol": "HRAS", "consequence": null}], "error": null}
{"id": "F5.1-000120-S1", "question": "In Melanoma Of Eye, which biomarkers have evidence?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'ocular' AND\n    toLower(rel.disease_name) CONTAINS 'melanoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE toLower(rel.disease_name) CONTAINS toLower('melanoma')\n  AND toLower(rel.disease_name) CONTAINS toLower('eye')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "KIT EXPRESSION", "gene_symbol": "KIT", "therapy_name": "Dasatinib", "effect": "sensitivity", "disease_name": "Ocular Melanoma", "pmids": ["21523734"]}], "generated_rows": [], "error": null}
{"id": "F5.1-000152-P3", "question": "What biomarkers have therapy response evidence in Childhood Pilocytic Astrocytoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'childhood' AND\n    toLower(rel.disease_name) CONTAINS 'pilocytic' AND\n    toLower(rel.disease_name) CONTAINS 'astrocytoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE toLower(rel.disease_name) CONTAINS toLower('childhood')\n  AND toLower(rel.disease_name) CONTAINS toLower('pilocytic')\n  AND toLower(rel.disease_name) CONTAINS toLower('astrocytoma')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  rel.effect AS effect,\n  coalesce(rel.pmids, []) AS pmids_for_row\nWHERE gene_symbol IS NOT NULL\nWITH gene_symbol, therapy_name, disease_name, effect, collect(pmids_for_row) AS all_pmids_lists\nUNWIND all_pmids_lists AS pmid_list_item\nUNWIND pmid_list_item AS pmid_single\nWITH gene_symbol, therapy_name, disease_name, effect, collect(DISTINCT pmid_single) AS pmids_aggregated\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  effect,\n  disease_name,\n  pmids_aggregated AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "BRAF V600E", "gene_symbol": "BRAF", "therapy_name": "Selumetinib", "effect": "sensitivity", "disease_name": "Childhood Pilocytic Astrocytoma", "pmids": ["31151904"]}, {"variant_name": "KIAA1549 KIAA1549::BRAF Fusion", "gene_symbol": "KIAA1549", "therapy_name": "Selumetinib", "effect": "sensitivity", "disease_name": "Childhood Pilocytic Astrocytoma", "pmids": ["31151904", "28002790"]}, {"variant_name": "KIAA1549 KIAA1549::BRAF Fusion", "gene_symbol": "KIAA1549", "therapy_name": "Sorafenib", "effect": "resistance", "disease_name": "Childhood Pilocytic Astrocytoma", "pmids": ["28002790"]}, {"variant_name": "KIAA1549 KIAA1549::BRAF Fusion", "gene_symbol": "KIAA1549", "therapy_name": "Trametinib", "effect": "sensitivity", "disease_name": "Childhood Pilocytic Astrocytoma", "pmids": ["28002790"]}, {"variant_name": "BRAF V600E", "gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "effect": "sensitivity", "disease_name": "Childhood Pilocytic Astrocytoma", "pmids": ["25524464"]}, {"variant_name": "KIAA1549 KIAA1549::BRAF Fusion", "gene_symbol": "KIAA1549", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Childhood Pilocytic Astrocytoma", "pmids": ["28002790"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "Selumetinib", "effect": "sensitivity", "disease_name": "Childhood Pilocytic Astrocytoma", "pmids": ["31151904"]}, {"variant_name": null, "gene_symbol": "KIAA1549", "therapy_name": "Selumetinib", "effect": "sensitivity", "disease_name": "Childhood Pilocytic Astrocytoma", "pmids": ["31151904", "28002790"]}, {"variant_name": null, "gene_symbol": "KIAA1549", "therapy_name": "Sorafenib", "effect": "resistance", "disease_name": "Childhood Pilocytic Astrocytoma", "pmids": ["28002790"]}, {"variant_name": null, "gene_symbol": "KIAA1549", "therapy_name": "Trametinib", "effect": "sensitivity", "disease_name": "Childhood Pilocytic Astrocytoma", "pmids": ["28002790"]}, {"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "effect": "sensitivity", "disease_name": "Childhood Pilocytic Astrocytoma", "pmids": ["25524464"]}, {"variant_name": null, "gene_symbol": "KIAA1549", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Childhood Pilocytic Astrocytoma", "pmids": ["28002790"]}], "error": null}
{"id": "F2.2-000035-S1", "question": "Which genes predict resistance to Aromatase Inhibitor in Mammary Tumor?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Aromatase Inhibitor')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Aromatase Inhibitor'))\n  OR toLower(t.name) CONTAINS toLower('Aromatase Inhibitor')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE toLower(rel.effect) = 'resistance'\n  AND any(tag IN coalesce(t.tags, []) WHERE toLower(tag) CONTAINS toLower('aromatase inhibitor'))\n  AND toLower(rel.disease_name) CONTAINS toLower('mammary')\n  AND toLower(rel.disease_name) CONTAINS toLower('tumor')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids_list\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids_list AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "gold_rows": [{"variant_name": null, "gene_symbol": "ESR1", "therapy_name": "Aromatase Inhibitor", "effect": "resistance", "disease_name": "Estrogen-receptor Positive Breast Cancer", "pmids": ["24185512"]}, {"variant_name": null, "gene_symbol": "KMT2C", "therapy_name": "Aromatase Inhibitor", "effect": "resistance", "disease_name": "Breast Cancer", "pmids": ["29755131"]}], "generated_rows": [], "error": null}
{"id": "F2.2-000064-P2", "question": "Which genes influence response to MTOR Kinase Inhibitor AZD8055 for Breast Cancer?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('MTOR Kinase Inhibitor AZD8055')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('MTOR Kinase Inhibitor AZD8055'))\n  OR toLower(t.name) CONTAINS toLower('MTOR Kinase Inhibitor AZD8055')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  NULL AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(t.name) = toLower('AZD8055')\n    OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('AZD8055'))\n    OR toLower(t.name) CONTAINS toLower('AZD8055')\n)\nAND toLower(rel.disease_name) CONTAINS toLower('breast')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n    CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n    t.name AS therapy_name,\n    rel.effect AS effect,\n    rel.disease_name AS disease_name,\n    coalesce(rel.pmids, []) AS pmids_raw\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids_raw AS p\nWITH gene_symbol, therapy_name, effect, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n    NULL AS variant_name,\n    gene_symbol,\n    therapy_name,\n    effect,\n    disease_name,\n    pmids\nLIMIT 100", "gold_rows": [{"variant_name": null, "gene_symbol": "MTOR", "therapy_name": "MTOR Kinase Inhibitor AZD8055", "effect": null, "disease_name": "Breast Cancer", "pmids": ["27279227"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "MTOR", "therapy_name": "MTOR Kinase Inhibitor AZD8055", "effect": "resistance", "disease_name": "Breast Cancer", "pmids": ["27279227"]}], "error": null}
{"id": "F2.2-000185-P1", "question": "What genes are predictive biomarkers for Uprosertib in Melanoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Uprosertib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Uprosertib'))\n  OR toLower(t.name) CONTAINS toLower('Uprosertib')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'melanoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  NULL AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(t.name) = toLower('uprosertib')\n    OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('uprosertib'))\n    OR toLower(t.name) CONTAINS toLower('uprosertib')\n)\nAND toLower(rel.disease_name) CONTAINS toLower('melanoma')\nAND (toLower(rel.effect) = 'sensitivity' OR toLower(rel.effect) = 'resistance')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n    CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n    t.name AS therapy_name,\n    rel.effect AS effect,\n    rel.disease_name AS disease_name,\n    coalesce(rel.pmids, []) AS pmids_list\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids_list AS p\nWITH gene_symbol, therapy_name, effect, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n    NULL AS variant_name,\n    gene_symbol,\n    therapy_name,\n    effect,\n    disease_name,\n    pmids\nLIMIT 100", "gold_rows": [{"variant_name": null, "gene_symbol": "AKT1", "therapy_name": "Uprosertib", "effect": null, "disease_name": "Melanoma", "pmids": ["24735930"]}, {"variant_name": null, "gene_symbol": "PTEN", "therapy_name": "Uprosertib", "effect": null, "disease_name": "Melanoma", "pmids": ["24735930"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "AKT1", "therapy_name": "Uprosertib", "effect": "sensitivity", "disease_name": "Melanoma", "pmids": ["24735930"]}, {"variant_name": null, "gene_symbol": "PTEN", "therapy_name": "Uprosertib", "effect": "sensitivity", "disease_name": "Melanoma", "pmids": ["24735930"]}], "error": null}
{"id": "F2.2-000040", "question": "Which genes affect response to Everolimus in Endometrial Carcinoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Everolimus')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Everolimus'))\n  OR toLower(t.name) CONTAINS toLower('Everolimus')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'endometrial' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  NULL AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(t.name) = toLower('everolimus')\n    OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('everolimus'))\n    OR toLower(t.name) CONTAINS toLower('everolimus')\n)\nAND toLower(rel.disease_name) CONTAINS toLower('endometrial')\nAND toLower(rel.disease_name) CONTAINS toLower('carcinoma')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n    CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n    t.name AS therapy_name,\n    rel.effect AS effect_val,\n    rel.disease_name AS disease_name,\n    coalesce(rel.pmids, []) AS pmids_list\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids_list AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids, collect(effect_val) AS all_effects\nRETURN\n    NULL AS variant_name,\n    gene_symbol,\n    therapy_name,\n    head(all_effects) AS effect,\n    disease_name,\n    pmids\nLIMIT 100", "gold_rows": [{"variant_name": null, "gene_symbol": "PTEN", "therapy_name": "Everolimus", "effect": null, "disease_name": "Endometrial Carcinoma", "pmids": ["23238879"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "PTEN", "therapy_name": "Everolimus", "effect": "sensitivity", "disease_name": "Endometrial Carcinoma", "pmids": ["23238879"]}], "error": null}
{"id": "F2.2-000050-S2-P2", "question": "List genes associated with resistance to Ipilimumab in Malignant Tumor.", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Ipilimumab')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Ipilimumab'))\n  OR toLower(t.name) CONTAINS toLower('Ipilimumab')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'cancer'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(t.name) = toLower('Ipilimumab')\n    OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Ipilimumab'))\n    OR toLower(t.name) CONTAINS toLower('Ipilimumab')\n)\nAND toLower(rel.effect) = 'resistance'\nAND toLower(rel.disease_name) CONTAINS toLower('malignant')\nAND toLower(rel.disease_name) CONTAINS toLower('tumor')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n    CASE\n        WHEN b:Gene THEN b.symbol\n        WHEN b:Variant THEN g.symbol\n        ELSE NULL\n    END AS gene_symbol,\n    t.name AS therapy_name,\n    rel.disease_name AS disease_name,\n    coalesce(rel.pmids, []) AS pmids_for_row,\n    rel.effect AS effect_val\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids_for_row AS pmid\nWITH gene_symbol, therapy_name, disease_name, effect_val, collect(DISTINCT pmid) AS pmids\nRETURN\n    NULL AS variant_name,\n    gene_symbol,\n    therapy_name,\n    effect_val AS effect,\n    disease_name,\n    pmids\nLIMIT 100", "gold_rows": [{"variant_name": null, "gene_symbol": "MDM2", "therapy_name": "Ipilimumab", "effect": "resistance", "disease_name": "Cancer", "pmids": ["28351930"]}], "generated_rows": [], "error": null}
{"id": "F5.1-000164-S1", "question": "In Malignant Melanoma Of Soft Tissues, which biomarkers have evidence?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'clear' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'sarcoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE toLower(rel.disease_name) CONTAINS toLower('malignant')\n  AND toLower(rel.disease_name) CONTAINS toLower('melanoma')\n  AND toLower(rel.disease_name) CONTAINS toLower('soft')\n  AND toLower(rel.disease_name) CONTAINS toLower('tissues')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "EWSR1 EWSR1::ATF1 Fusion", "gene_symbol": "EWSR1", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Clear Cell Sarcoma", "pmids": ["29741569"]}, {"variant_name": "MET Overexpression AND EWSR1::ATF1 Fusion", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Clear Cell Sarcoma", "pmids": ["28950372"]}, {"variant_name": "EWSR1 EWSR1::ATF1 Fusion", "gene_symbol": "EWSR1", "therapy_name": "Trabectedin", "effect": "sensitivity", "disease_name": "Clear Cell Sarcoma", "pmids": ["38074516"]}, {"variant_name": "BRAF V600E", "gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "effect": "sensitivity", "disease_name": "Clear Cell Sarcoma", "pmids": ["26286452"]}, {"variant_name": "KRAS K117N", "gene_symbol": "KRAS", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Clear Cell Sarcoma", "pmids": ["22205714"]}], "generated_rows": [], "error": null}
